Dynamic Technology Lab Private LTD Bio N Tech Se Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $10,545 - $13,079	116 Added 2.55%	4,666 $492,000
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $448,175 - $569,114	4,550 New	4,550 $494,000
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $695,952 - $872,538	5,678 Added 122.85%	10,300 $1.28 Million
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $547,383 - $859,923	4,622 New	4,622 $694,000
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $92,437 - $139,680	-750 Reduced 30.24%	1,730 $258,000
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $265,125 - $486,885	-2,100 Reduced 45.85%	2,480 $423,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $708,629 - $1.19 Million	3,271 Added 249.89%	4,580 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $364,907 - $792,491	-1,772 Reduced 57.51%	1,309 $357,000
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $349,138 - $744,030	3,081 New	3,081 $690,000
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $311,885 - $434,741	-3,638 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$72.71 - $129.54 $264,518 - $471,266	3,638 New	3,638 $297,000

328

40.6M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.